A global strategy is launched today to coordinate the complex research activities necessary for a new approach to coronavirus vaccine development. The aim is to develop more effective, longer lasting vaccines against continually ...
Feb 21, 2023
0
6
Many vaccine trials use age de-escalation with the goal of safeguarding the interests of younger, more vulnerable populations. After a vaccine's safety and efficacy are established in adult populations, progressively younger ...
Feb 21, 2023
0
20
People who know someone who became ill with COVID-19 or died from the disease are twice as likely to receive a COVID-19 vaccine, according to a study led by Rutgers and Penn State University.
Feb 3, 2023
0
2
University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy ...
Jan 10, 2023
0
3
The first reports that several women experienced menstrual disturbances after coronavirus vaccination came early in summer 2021. The Norwegian Institute of Public Health (NIPH) promptly introduced questions about menstrual ...
Dec 19, 2022
0
34
The percentage of children with up-to-date human papillomavirus (HPV) vaccine coverage remains lower compared with pre-COVID-19 pandemic levels, according to a study published in the November issue of Vaccine.
Dec 15, 2022
0
37
Vaccine-resistant pneumonia has increased since a vaccine targeting 13 serotypes of the Streptococcus pneumoniae bacteria was introduced into the Australian routine childhood immunization program.
Dec 1, 2022
0
8
A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic.
Nov 7, 2022
0
6
Cancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and therapies that may weaken the immune system. The development of COVID-19 vaccines has greatly reduced mortality associated ...
Oct 4, 2022
0
48
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body's immune system attacks the nerves, according to a Rutgers-led study.
Oct 4, 2022
0
80
